SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-20-024400
Filing Date
2020-09-04
Accepted
2020-09-04 20:00:29
Documents
2
Period of Report
2020-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 11226
2 EX-24 DOCUMENT attachment1.htm EX-24 5338
  Complete submission text file 0000899243-20-024400.txt   17920
Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DICERNA PHARMACEUTICALS, INC. 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Weissman James B (Reporting) CIK: 0001598480 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36281 | Film No.: 201162759